Cargando…

Steroids are part of rescue therapy in ARDS patients with refractory hypoxemia: no

Detalles Bibliográficos
Autores principales:	Thompson, B. Taylor, Ranieri, V. Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829481/ https://www.ncbi.nlm.nih.gov/pubmed/26883256 http://dx.doi.org/10.1007/s00134-016-4255-1

Ejemplares similares

The standard of care of patients with ARDS: ventilatory settings and rescue therapies for refractory hypoxemia
por: Bein, Thomas, et al.
Publicado: (2016)

Rescue strategies for refractory hypoxemia: a critical appraisal
por: Villar, Jesús, et al.
Publicado: (2009)

Bosentan as Rescue Treatment in Refractory Hypoxemia and Pulmonary Hypertension in a Patient with ARDS and H7N9 Influenza Virus Infection
por: Guo, Qiang, et al.
Publicado: (2014)

Management of refractory hypoxemia using recruitment maneuvers and rescue therapies: A comprehensive review
por: Bajon, Félix, et al.
Publicado: (2023)

Management of refractory hypoxemia
por: Mehta, Chitra, et al.
Publicado: (2016)

Steroid treatment for persistent ARDS: a word of caution
por: Thompson, B Taylor, et al.
Publicado: (2007)

Steroids in late ARDS?
por: Wajanaponsan, Non, et al.
Publicado: (2007)

Steroids in early ARDS?
por: Aldabbagh, Tarek, et al.
Publicado: (2007)

Inhaled pulmonary vasodilators in refractory hypoxemia
por: Wright, Brian J.
Publicado: (2015)

Is severe COVID-19 pneumonia a typical or atypical form of ARDS? And does it matter?
por: Goligher, Ewan C., et al.
Publicado: (2020)

Intravenous Methylene Blue as a Rescue Therapy in the Management of Refractory Hypoxia in COVID-19 ARDS Patients: A Case Series
por: Mahale, Nilesh, et al.
Publicado: (2021)

Trajectories of hypoxemia and pulmonary mechanics of COVID-19 ARDS in the NorthCARDS dataset
por: Jafari, Daniel, et al.
Publicado: (2022)

Avoidance of hypoxemia in COPD is essential
por: Rodríguez-Llamazares, Sebastián, et al.
Publicado: (2020)

Patients Choose Hypoxemia over Social Isolation
por: Jacobs, Susan S., et al.
Publicado: (2021)

Hypoxemia on life support for guiding acute respiratory distress syndrome therapy?
por: Gusman, Elen, et al.
Publicado: (2020)

Successful use of inhaled epoprostenol as rescue therapy for pediatric ARDS
por: Urich, Alissa, et al.
Publicado: (2020)

Metabolomics based predictive biomarker model of ARDS: A systemic measure of clinical hypoxemia
por: Viswan, Akhila, et al.
Publicado: (2017)

A Case Report of Cyanosis With Refractory Hypoxemia: Is It Methemoglobinemia?
por: Kamath, Sangita D, et al.
Publicado: (2022)

Nitric oxide versus epoprostenol for refractory hypoxemia in Covid-19
por: Poonam, Pai B. H., et al.
Publicado: (2022)

Correction: Metabolomics based predictive biomarker model of ARDS: A systemic measure of clinical hypoxemia
Publicado: (2018)

Refractory hypoxemia caused by hepatopulmonary syndrome: a case report
por: Govindan, Morgen L, et al.
Publicado: (2014)

The rescue effect of adalimumab in the treatment of refractory pediatric panuveitis complicated with steroid-induced glaucoma
por: Ku, Wei-Ning, et al.
Publicado: (2018)

Case Report: Eculizumab and ECMO Rescue Therapy of Severe ARDS in Goodpasture Syndrome
por: Sobotta, Michael, et al.
Publicado: (2021)

Extracorporeal membrane oxygenation circuits in parallel for refractory hypoxemia in patients with COVID-19
por: Patel, Yatrik J., et al.
Publicado: (2022)

Screening for the causes of refractory hypoxemia in critically ill patients: A case report
por: Liu, Wanglin, et al.
Publicado: (2022)

Refractory Hypoxemia Despite Extracorporeal Membrane Oxygenation: Point-of-Care Ultrasound Is Needed for Patients With COVID-19
por: Rali, Aniket S., et al.
Publicado: (2021)

Optimizing Mechanical Ventilation in Refractory ARDS
por: Terzi, Nicolas, et al.
Publicado: (2022)

Steroids in ARDS: more light is being shed
por: Arulkumaran, Nishkantha, et al.
Publicado: (2020)

Dapsone: a steroid-sparing drug for refractory immunoglobulin A vasculitis?
por: Suh, Jin-Soon
Publicado: (2020)

Toward the establishment of guidelines for the treatment of steroid‐refractory immune‐related hepatotoxicity
por: Yoshio, Sachiyo
Publicado: (2023)

Effect of pre-operative hypoxemia on the occurrence and outcomes of post-operative ARDS in Stanford type a aortic dissection patients
por: Teng Cai, et al.
Publicado: (2023)

Special Issue “Clinical and Physiological Consequences of Hypoxia/Hypoxemia in Healthy Subjects and Patients”
por: Meyer, Michelle, et al.
Publicado: (2022)

Effective and Safe Use of Glucocorticosteroids for Rescue of Late ARDS
por: Diana, Paolo, et al.
Publicado: (2017)

Infliximab as rescue therapy in refractory Kawasaki disease
por: Rodríguez-González, Moisés, et al.
Publicado: (2014)

Fibrinolytics as an ARDS Salvage Option: Promising, But ARDS Prevention Options Are Needed Urgently
por: Cap, Andrew P.
Publicado: (2022)

Effects of Inhaled Epoprostenol and Prone Positioning in Intubated Coronavirus Disease 2019 Patients With Refractory Hypoxemia
por: Li, Jie, et al.
Publicado: (2020)

REFRACTORY HYPOXEMIA: A CASE OF DAPSONE-INDUCED METHEMOGLOBINEMIA IN A PATIENT WITH COVID-19
por: ALONSO, MILEYDIS, et al.
Publicado: (2022)

Adjunctive Therapies in ARDS: The Disconnect Between Clinical Trials and Clinical Practice
por: Qadir, Nida, et al.
Publicado: (2020)

Stellate Ganglion Block as Rescue Therapy in Refractory Ventricular Tachycardia
por: Rajesh, M. C., et al.
Publicado: (2017)

COVID-19 pneumonia: ARDS or not?
por: Gattinoni, Luciano, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7u6qep7mh4ksv5dbj1gu3chjqk